Chicago Partners Investment Group LLC Volitionrx LTD Transaction History
Chicago Partners Investment Group LLC
- $3.5 Billion
- Q3 2025
A detailed history of Chicago Partners Investment Group LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 16,168 shares of VNRX stock, worth $5,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,168
Previous 17,713
8.72%
Holding current value
$5,335
Previous $13,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VNRX
# of Institutions
32Shares Held
26.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY12.5MShares$4.12 Million4.96% of portfolio
-
Armistice Capital, LLC New York, NY9.38MShares$3.1 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.53MShares$504,9150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA878KShares$289,7960.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$170,3040.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $18.9M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...